Clinic
Indiana University Health Arnett INC
Indiana University Health Arnett INC was paid $26.01M by Medicaid between Jan 2018 and Nov 2024, across 136 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoINDIANA UNIVERSITY HEALTH ARNETT INC
LAFAYETTE, IN 47905
LAFAYETTE, IN 47905
33aNPI1326296211assigned 09/04/2008
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$26.01M
24GClaims450,171
24DCodes billed136
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Indiana
Rank by total paid#3 of 87
Median peer was paid$115K
This provider vs. median226×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CRAIG, MICHAEL controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,207 | $1.42M | |
| 2019 | 45,182 | $2.38M | |
| 2020 | 45,835 | $2.48M | |
| 2021 | 66,482 | $4.32M | |
| 2022 | 100,598 | $6.42M | |
| 2023 | 81,448 | $5.56M | |
| 2024incomplete | 51,419 | $3.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 24,964 | 22,726 | $4.29M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 25,384 | 22,413 | $4.00M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 29,388 | 25,180 | $3.85M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.8% | 4,438 | 3,814 | $1.52M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.0% | 26,456 | 22,686 | $1.29M |
| 71045 | Radiologic examination, chest; single view | 4.9% | 9,014 | 7,718 | $1.28M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 4.7% | 687 | 593 | $1.23M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.4% | 18,303 | 15,469 | $1.14M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.7% | 806 | 665 | $696K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 9,551 | 9,067 | $686K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.4% | 17,777 | 15,330 | $632K |
| 71046 | Radiologic examination, chest; 2 views | 2.3% | 6,353 | 5,608 | $610K |
124 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 5,794 | $470K |
| 62323 | 1.5% | 462 | $378K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 867 | $349K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.3% | 1,963 | $325K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 3,118 | $294K |
| 80053 | Comprehensive metabolic panel | <1% | 42,662 | $251K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 47,576 | $204K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 134 | $193K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 4,310 | $181K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 7,844 | $149K |
| 80320 | <1% | 1,448 | $138K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 33,815 | $137K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,958 | $134K |
| 87503 | <1% | 4,564 | $110K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,695 | $99K |
| 97597 | <1% | 656 | $86K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,162 | $84K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,092 | $81K |
| 80050 | General health panel | <1% | 664 | $78K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,443 | $67K |
| 84484 | <1% | 11,420 | $62K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 11,581 | $55K |
| 81025 | <1% | 9,826 | $54K | |
| 59025 | Fetal non-stress test | <1% | 178 | $47K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 269 | $41K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,666 | $41K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 624 | $39K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 30 | $38K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 631 | $38K |
| 83690 | <1% | 11,444 | $38K | |
| 36591 | <1% | 716 | $35K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 939 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 910 | $28K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 949 | $28K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 145 | $27K |
| 81001 | <1% | 13,243 | $23K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 116 | $23K |
| 29581 | <1% | 162 | $22K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,204 | $21K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 646 | $19K |
| 80329 | <1% | 324 | $18K | |
| 96367 | <1% | 479 | $17K | |
| 87276 | <1% | 1,827 | $15K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 410 | $14K |
| 84439 | <1% | 2,126 | $14K | |
| 80061 | Lipid panel | <1% | 1,625 | $13K |
| 87275 | <1% | 1,827 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,206 | $13K |
| 83735 | <1% | 3,238 | $12K | |
| 81003 | <1% | 8,526 | $12K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,256 | $11K |
| 87536 | <1% | 158 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,773 | $9K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 169 | $8K |
| 86780 | <1% | 599 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,833 | $7K |
| 83880 | <1% | 360 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 403 | $6K |
| 74018 | <1% | 35 | $6K | |
| 80143 | <1% | 387 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $5K |
| 85027 | <1% | 1,325 | $5K | |
| 83605 | <1% | 851 | $5K | |
| 88142 | <1% | 250 | $4K | |
| 29580 | <1% | 33 | $3K | |
| 86140 | <1% | 959 | $3K | |
| 96415 | <1% | 27 | $3K | |
| 84100 | <1% | 1,112 | $3K | |
| 80076 | <1% | 431 | $2K | |
| 86360 | <1% | 57 | $2K | |
| 82728 | <1% | 181 | $2K | |
| 85652 | <1% | 1,076 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 96 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $2K |
| 80069 | <1% | 530 | $2K | |
| 86359 | <1% | 57 | $2K | |
| 82550 | <1% | 434 | $1K | |
| 85610 | <1% | 743 | $1K | |
| 87040 | <1% | 336 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 41 | $1K |
| 82607 | <1% | 97 | $928.15 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 39 | $894.34 |
| 84702 | <1% | 84 | $883.43 | |
| 82570 | <1% | 333 | $868.67 | |
| 87807 | <1% | 81 | $813.85 | |
| 83970 | <1% | 65 | $804.14 | |
| 85379 | <1% | 100 | $790.08 | |
| 87510 | <1% | 42 | $741.85 | |
| 87480 | <1% | 42 | $741.85 | |
| 87660 | <1% | 42 | $741.85 | |
| 73630 | <1% | 15 | $571.05 | |
| 86003 | <1% | 299 | $539.95 | |
| 86803 | <1% | 39 | $529.96 | |
| 85730 | <1% | 149 | $455.25 | |
| 87150 | <1% | 14 | $385.99 | |
| 84156 | <1% | 239 | $372.21 | |
| 87340 | <1% | 39 | $329.06 | |
| 87653 | <1% | 12 | $280.72 | |
| 83550 | <1% | 44 | $244.21 | |
| 82043 | <1% | 55 | $224.55 | |
| 82948 | <1% | 113 | $213.14 | |
| 87400 | <1% | 12 | $192.96 | |
| 82248 | <1% | 100 | $189.99 | |
| 83540 | <1% | 44 | $182.02 | |
| 84460 | <1% | 111 | $169.68 | |
| 86850 | <1% | 26 | $137.89 | |
| 87210 | <1% | 19 | $98.90 | |
| 84550 | <1% | 53 | $76.21 | |
| 86901 | <1% | 26 | $73.47 | |
| 86900 | <1% | 26 | $73.47 | |
| 82950 | <1% | 14 | $57.00 | |
| 81002 | <1% | 16 | $6.86 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 213 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 18 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 425 | $0.00 |
| 96376 | 0% | 18 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 169 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 15 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 30 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 34 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 23 | $0.00 |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 311 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 323 | $0.00 |
| A6021 | Collagen dressing, sterile, size 16 sq. in. or less, each | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRAIG, MICHAEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Indiana University Health Southern Indiana Physicians, LLC | Bloomington, IN | $69.64M |
| Indiana University Health Bloomington INC | Bloomington, IN | $28.69M |
| Southern Indiana Pediatrics, LLC | Bloomington, IN | $10.70M |
| Indiana University Health Bedford, INC | Bedford, IN | $8.45M |
| Indiana University Health Paoli INC | Paoli, IN | $4.44M |
| Indiana University Health Bloomington INC | Bloomington, IN | $1.49M |
| Indiana University Health Paoli INC | Paoli, IN | $1.10M |
| Iu Health Bedford Physicians, LLC | Bedford, IN | $1000K |
| Iu Health Morgan Physicians, LLC | Martinsville, IN | $534K |
| Wagoner Family Dentistry, PC | Wagoner, OK | $510K |
| Orthopedics of South Central Indiana LLC | Bloomington, IN | $239K |
| Ambulance Service of Murfreesboro, LLC | Murfreesboro, TN | $16K |
| Bloomington Endoscopy Center, LLC | Bloomington, IN | $0.00 |
| Indiana University Health Southern Indiana Physicians, LLC | Bloomington, IN | $0.00 |
| Indiana University Health Southern Indiana Physicians LLC | Bloomington, IN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.